樂觀
$5.83
情境價格
$14.800
-0.759 (-5.13%)收盤時
Paysign, Inc. is a provider of prepaid card programs, patient affordability offerings, digital banking services and integrated payment processing designed for businesses, consumers and government institutions. The Company’s payment solutions are utilized by its corporate customers to increase customer loyalty, increase patient adherence rates, reduce administration costs and streamline operations. It markets its prepaid card solutions under its Paysign brand. Its end-to-end technologies securely enable digital payout solutions and facilitate the distribution of funds for donor compensation, copay assistance, employee rewards, travel expenses, per diem, reimbursements, rebates, and countless other exchanges of value. It operates on a payments platform with fintech capabilities that can be seamlessly integrated with its clients’ systems. It offers donor engagement app, which integrates seamlessly with existing donor management systems, delivering immediate value to plasma centers.
Paysign Inc is a good buy right now due to its strong recent performance, with a current price of $15.37 and a year-to-date change of +209.88%. The company reported a Q2 EPS of $0.11, exceeding expectations by $0.05, and raised its full-year revenue guidance to between $114 million and $117 million, showcasing robust growth potential. However, the main risk is the high forward P/E ratio of 29.59, which suggests that the stock may be overvalued if growth slows.
情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

Paysign to Discuss Q3 2026 Earnings on November 9

Paysign Reports Record Q2 Earnings, Raises Full-Year Guidance

Paysign Q2 Earnings Exceed Expectations

Global X Announces July 2026 ETF Distributions

Paysign to Discuss Q2 2026 Earnings on August 5
Paysign, Inc. is a provider of prepaid card programs, patient affordability offerings, digital banking services and integrated payment processing designed for businesses, consumers and government institutions. The Company’s payment solutions are utilized by its corporate customers to increase customer loyalty, increase patient adherence rates, reduce administration costs and streamline operations. It markets its prepaid card solutions under its Paysign brand. Its end-to-end technologies securely enable digital payout solutions and facilitate the distribution of funds for donor compensation, copay assistance, employee rewards, travel expenses, per diem, reimbursements, rebates, and countless other exchanges of value. It operates on a payments platform with fintech capabilities that can be seamlessly integrated with its clients’ systems. It offers donor engagement app, which integrates seamlessly with existing donor management systems, delivering immediate value to plasma centers. It operates in the Industrials sector (SERVICES-BUSINESS SERVICES, NEC industry).
Paysign Inc is a good buy right now due to its strong recent performance, with a current price of $15.37 and a year-to-date change of +209.88%. The company reported a Q2 EPS of $0.11, exceeding expectations by $0.05, and raised its full-year revenue guidance to between $114 million and $117 million, showcasing robust growth potential. However, the main risk is the high forward P/E ratio of 29.59, which suggests that the stock may be overvalued if growth slows.
暫無貼文
註冊或登入後參與討論本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。